Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02553174 · ClinicalTrials.gov registry record
AKI in Thoracic and Abdominal Surgery
A clinical trial, sponsored by Milton S. Hershey Medical Center.
- Terminated
- Registry status
- 50
- Enrollment target
NCT02553174: Clinical Trial study, sponsored by Milton S. Hershey Medical Center.
NCT02553174 is a clinical trial that was terminated before completion, run by Milton S. Hershey Medical Center. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02553174 was terminated before completion, sponsored by Milton S. Hershey Medical Center.
- TERMINATED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The study will investigate the role of NSAIDs in the development of AKI in patients undergoing high-risk abdominal or thoracic surgery. The investigators hypothesize that the use of new urinary biomarkers will allow earlier detection of AKI than the current gold standard, i.e. changes in serum creatinine and/or urine output.
Primary Outcome
AKI defined by change in serum creatinine from baseline and change in urine output (KDIGO criteria)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-06-01 |
| Est. Completion | 2018-03-23 |
Why NCT02553174 stopped before completion
NCT02553174 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02553174 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02553174 about?
NCT02553174 is a clinical study titled "AKI in Thoracic and Abdominal Surgery". The study will investigate the role of NSAIDs in the development of AKI in patients undergoing high-risk abdominal or thoracic surgery. The investigators hypothesize that the use of new urinary biomarkers will allow earlier detection of AKI than the current gold standard, i.e. changes in serum creat...
What is the current status of trial NCT02553174?
This trial is currently terminated. The enrollment target is 50 participants. The study started on 2016-06-01. Estimated completion is 2018-03-23.
Who is sponsoring clinical trial NCT02553174?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI